AlphaYouNC
Schedule 13D filing
Nant Capital, LLC disclosed a 19.9% stake in PDS Biotechnology Corp (PDSB)
Nant Capital, LLC reported owning 19.9% of PDS Biotechnology Corp (PDSB) (20,336,335 shares) in a Schedule 13D filed Sep 22, 2026.
A 13D means the holder may push for changes at the company.
- Disclosed
- Sep 22, 2026
- Source
- Schedule 13D
From a public Schedule 13D, linked above. Not investment advice, and not a recommendation to buy or sell.